Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

UHPLC-Q/Orbitrap/MS/MS Fingerprinting, Free Radical Scavenging, and Antimicrobial Activity of Tessaria absinthiodes (Hook. & Arn.) DC. (Asteraceae) Lyophilized Decoction from Argentina and Chile.

Gómez J, Simirgiotis MJ, Lima B, Gamarra-Luques C, Bórquez J, Caballero D, Feresin GE, Tapia A.

Antioxidants (Basel). 2019 Nov 28;8(12). pii: E593. doi: 10.3390/antiox8120593.

2.

Antioxidant, Gastroprotective, Cytotoxic Activities and UHPLC PDA-Q Orbitrap Mass Spectrometry Identification of Metabolites in Baccharis grisebachii Decoction.

Gómez J, Simirgiotis MJ, Lima B, Paredes JD, Villegas Gabutti CM, Gamarra-Luques C, Bórquez J, Luna L, Wendel GH, Maria AO, Feresin GE, Tapia A.

Molecules. 2019 Mar 19;24(6). pii: E1085. doi: 10.3390/molecules24061085.

3.

Editorial: The European Patients Academy on Therapeutic Innovation (EUPATI) Guidelines on Patient Involvement in Research and Development.

Spindler P, Lima BS.

Front Med (Lausanne). 2018 Nov 8;5:310. doi: 10.3389/fmed.2018.00310. eCollection 2018. No abstract available.

4.

Cardiovascular adverse events associated with oral antineoplastic therapy.

Silva JMD, Lima BDS, Araújo TL, Lima FET, Cunha GHD.

Rev Bras Enferm. 2018 Sep-Oct;71(5):2561-2569. doi: 10.1590/0034-7167-2017-0450. Review. English, Portuguese.

5.

Proteome analysis of Phytomonas serpens, a phytoparasite of medical interest.

Dos Santos Júnior ACM, Ricart CAO, Pontes AH, Fontes W, Souza AR, Castro MS, de Sousa MV, de Lima BD.

PLoS One. 2018 Oct 10;13(10):e0204818. doi: 10.1371/journal.pone.0204818. eCollection 2018.

6.

PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis.

Barroso DH, Falcão SAC, da Motta JOC, Sevilha Dos Santos L, Takano GHS, Gomes CM, Favali CBF, de Lima BD, Sampaio RNR.

Front Immunol. 2018 May 11;9:1021. doi: 10.3389/fimmu.2018.01021. eCollection 2018.

7.

The Antimicrobial Activity of Annona emarginata (Schltdl.) H. Rainer and Most Active Isolated Compounds against Clinically Important Bacteria.

Dolab JG, Lima B, Spaczynska E, Kos J, Cano NH, Feresin G, Tapia A, Garibotto F, Petenatti E, Olivella M, Musiol R, Jampilek J, Enriz RD.

Molecules. 2018 May 16;23(5). pii: E1187. doi: 10.3390/molecules23051187.

8.

UHPLC-MS Metabolome Fingerprinting: The Isolation of Main Compounds and Antioxidant Activity of the Andean Species Tetraglochin ameghinoi (Speg.) Speg.

Luna L, Simirgiotis MJ, Lima B, Bórquez J, Feresin GE, Tapia A.

Molecules. 2018 Mar 29;23(4). pii: E793. doi: 10.3390/molecules23040793.

9.

American cutaneous leishmaniasis triggered by electrocoagulation.

Martins SS, Santos AO, Lima BD, Gomes CM, Sampaio RNR.

Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):108-110. doi: 10.1590/0037-8682-0306-2017.

10.

Effects of PI3K and FSH on steroidogenesis, viability and embryo development of the cumulus-oocyte complex after in vitro culture.

de Souza DK, Salles LP, Camargo R, Gulart LVM, Costa E Silva S, de Lima BD, Torres FAG, Rosa E Silva AAM.

Zygote. 2018 Feb;26(1):50-61. doi: 10.1017/S0967199417000703. Epub 2017 Dec 13.

PMID:
29233229
11.

Synthesis, characterization and biological studies of a cobalt(III) complex of sulfathiazole.

Pontoriero A, Mosconi N, Monti L, Bellú S, Williams PAM, Raimondi M, Lima B, Feresin GE, Nerli B, Rizzotto M.

Chem Biol Interact. 2017 Dec 25;278:152-161. doi: 10.1016/j.cbi.2017.10.004. Epub 2017 Oct 5.

PMID:
28987326
12.

Estimating (131)I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification.

Willegaignon J, Pelissoni RA, Lima BC, Sapienza MT, Coura-Filho GB, Queiroz MA, Buchpiguel CA.

Radiol Bras. 2016 May-Jun;49(3):150-7. doi: 10.1590/0100-3984.2015.0079.

13.

Small Peptides Derived from Penetratin as Antibacterial Agents.

Parravicini O, Somlai C, Andujar SA, Garro AD, Lima B, Tapia A, Feresin G, Perczel A, Tóth G, Cascales JL, Rodríguez AM, Enriz RD.

Arch Pharm (Weinheim). 2016 Apr;349(4):242-51. doi: 10.1002/ardp.201500419. Epub 2016 Mar 11.

PMID:
26972341
14.

Prediction of iodine-131 biokinetics and radiation doses from therapy on the basis of tracer studies: an important question for therapy planning in nuclear medicine.

Willegaignon J, Pelissoni RA, Lima BC, Sapienza MT, Coura-Filho GB, Buchpiguel CA.

Nucl Med Commun. 2016 May;37(5):473-9. doi: 10.1097/MNM.0000000000000465.

PMID:
26671852
15.

Antibacterial Activity, Antioxidant Effect and Chemical Composition of Propolis from the Región del Maule, Central Chile.

Nina N, Quispe C, Jiménez-Aspee F, Theoduloz C, Feresín GE, Lima B, Leiva E, Schmeda-Hirschmann G.

Molecules. 2015 Oct 6;20(10):18144-67. doi: 10.3390/molecules201018144.

16.

Unveiling the Trypanosoma cruzi Nuclear Proteome.

dos Santos Júnior Ade C, Kalume DE, Camargo R, Gómez-Mendoza DP, Correa JR, Charneau S, de Sousa MV, de Lima BD, Ricart CA.

PLoS One. 2015 Sep 18;10(9):e0138667. doi: 10.1371/journal.pone.0138667. eCollection 2015.

17.

A new series of antibacterial nitrosopyrimidines: synthesis and structure-activity relationship.

Olivella M, Marchal A, Nogueras M, Melguizo M, Lima B, Tapia A, Feresin GE, Parravicini O, Giannini F, Andujar SA, Cobo J, Enriz RD.

Arch Pharm (Weinheim). 2015 Jan;348(1):68-80. doi: 10.1002/ardp.201400271. Epub 2014 Nov 21.

PMID:
25413501
18.

Quantitative proteomic and phosphoproteomic analysis of Trypanosoma cruzi amastigogenesis.

Queiroz RM, Charneau S, Mandacaru SC, Schwämmle V, Lima BD, Roepstorff P, Ricart CA.

Mol Cell Proteomics. 2014 Dec;13(12):3457-72. doi: 10.1074/mcp.M114.040329. Epub 2014 Sep 15.

19.

Anti-inflammatory activity of animal oils from the Peruvian Amazon.

Schmeda-Hirschmann G, Delporte C, Valenzuela-Barra G, Silva X, Vargas-Arana G, Lima B, Feresin GE.

J Ethnopharmacol. 2014 Oct 28;156:9-15. doi: 10.1016/j.jep.2014.08.010. Epub 2014 Aug 21.

PMID:
25150527
20.

Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.

Sewell F, Chapman K, Baldrick P, Brewster D, Broadmeadow A, Brown P, Burns-Naas LA, Clarke J, Constan A, Couch J, Czupalla O, Danks A, DeGeorge J, de Haan L, Hettinger K, Hill M, Festag M, Jacobs A, Jacobson-Kram D, Kopytek S, Lorenz H, Moesgaard SG, Moore E, Pasanen M, Perry R, Ragan I, Robinson S, Schmitt PM, Short B, Lima BS, Smith D, Sparrow S, van Bekkum Y, Jones D.

Regul Toxicol Pharmacol. 2014 Oct;70(1):413-29. doi: 10.1016/j.yrtph.2014.07.018. Epub 2014 Jul 29.

Supplemental Content

Loading ...
Support Center